The cerebrospinal fluid management (csf) devices and equipment market size has grown strongly in recent years. It will grow from $1.1 billion in 2023 to $1.16 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth observed in the historical period can be attributed to the increasing incidence of neurological disorders, an aging population, heightened awareness and education, government initiatives and funding, rising healthcare expenditure, as well as collaborations and partnerships.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see marginal growth in the next few years. It will grow to $1.22 billion in 2028 at a compound annual growth rate (CAGR) of 1.4%. The anticipated growth in the forecast period can be attributed to the increasing geriatric population, global healthcare infrastructure development, rising awareness, and screening programs, expanding applications, as well as emerging markets and untapped regions. Key trends during the forecast period include continued technological innovations, advancements in technology, growing awareness and diagnosis rates, the regulatory landscape, and patient-centric approaches.
The anticipated rise in neurological disorders is set to drive the expansion of the cerebrospinal fluid (CSF) devices market. Neurological disorders, affecting the brain, nerves, and spinal cord, prompt the use of CSF devices for diagnosis, monitoring, and treatment. As per the Alzheimer's Association's 2023 Alzheimer's Disease Facts and Figures, the cost of Alzheimer's and related dementias is projected to reach $345 billion in 2023, with estimates of nearly $1 trillion by 2050. This surge in neurological disorders underscores the growth of the cerebrospinal fluid (CSF) devices market.
An increase in the number of brain surgeries contributes to the demand for cerebrospinal fluid (CSF) devices. These devices, crucial in treating traumatic brain injuries (TBI), particularly utilize shunts to drain accumulated cerebrospinal fluid. In the United States, TBI is a leading cause of death, with 1.5 to 2 million adults and children experiencing it annually. Given the prevalence of brain injuries, the CSF devices market is poised for continual growth.
A significant constraint on the cerebrospinal fluid (CSF) devices market is the high such as lihood of shunt failure or malfunction. Shunts are employed to manage Hydrocephalus, a condition involving the accumulation of excess cerebrospinal fluid (CSF) near the brain. Research published on the National Library of Medicine in 2021 revealed a 30% complication rate within 30 days of shunting procedures, with 58% requiring at least one revision. Trust issues arise due to the substantial shunt failure rate, leading patients to seek alternative treatments.
The latest trend in the cerebrospinal fluid devices market involves the implementation of new and improved sensors. This trend holds potential for boosting growth rates and enhancing diagnostic quality. Addressing the complexities of treating Hydrocephalus, high-precision devices with new sensors and telemetry devices are being explored. Northwestern University's Rogers research group has developed an advanced skin sensor that can reduce malfunctions and the need for brain surgeries. The sensor, utilizing body temperature readings, provides information on CSF leakage and offers distinct heat signatures indicating shunt functionality.
Major players in the cerebrospinal fluid (CSF) devices market are introducing innovative products to meet unmet needs, such as the ReFlow Mini Flusher device. Launched by Anuncia Medical Inc. in July 2023, this second-generation device aims to treat hydrocephalus. Its compact design, reduced size, and simplified operation make it a promising innovation in hydrocephalus treatment.
While the US Food and Drug Administration (FDA) classifies CSF devices as class II devices, regulatory compliance involves a stringent protocol. This includes addressing potential health risks, submitting a cover sheet describing the device, providing a summary report, and ensuring biocompatibility and appropriate labeling. Adhering to these regulatory guidelines may extend the product release timeline and increase overall development costs, impacting the market.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market report are Biometrix Healthcare Pvt. Ltd., Delta Surgical Limited, Medtronic PLC, Stryker Corporation, B. Braun, DePuy Synthes, Olympus Corporation, Nitto Denko Corporation, Terumo Corporation, Mindray Medical International Limited, Mettler-Toledo International Inc., IMI Norgren Ltd., Maquet Getinge Group AB, Karl Storz GmbH & Co. KG, Smiths Medical Inc., Elekta AB, Integra LifeSciences Holdings Corporation, Brainlab AG, Penumbra Inc., Leica Biosystems Inc., Danobat S. Coop., Fujifilm Medical Systems USA Inc., Natus Medical Incorporated, G. Surgiwear Ltd., Sophysa USA Inc., Möller Medical GmbH, Wellong Instruments Co. Ltd., Argi Grup, Spiegelberg GmbH & Co. KG, BeckerSmith Medical Inc., Dispomedica GmbH. North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2023. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
The cerebrospinal fluid (CSF) management devices and equipment market research report is one of a series of new reports that provides cerebrospinal fluid (CSF) management devices and equipment market statistics, including cerebrospinal fluid (CSF) management devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid (CSF) management devices and equipment market share, detailed cerebrospinal fluid (CSF) management devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid (CSF) management devices and equipment industry. This cerebrospinal fluid (CSF) management devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see marginal growth in the next few years. It will grow to $1.22 billion in 2028 at a compound annual growth rate (CAGR) of 1.4%. The anticipated growth in the forecast period can be attributed to the increasing geriatric population, global healthcare infrastructure development, rising awareness, and screening programs, expanding applications, as well as emerging markets and untapped regions. Key trends during the forecast period include continued technological innovations, advancements in technology, growing awareness and diagnosis rates, the regulatory landscape, and patient-centric approaches.
The anticipated rise in neurological disorders is set to drive the expansion of the cerebrospinal fluid (CSF) devices market. Neurological disorders, affecting the brain, nerves, and spinal cord, prompt the use of CSF devices for diagnosis, monitoring, and treatment. As per the Alzheimer's Association's 2023 Alzheimer's Disease Facts and Figures, the cost of Alzheimer's and related dementias is projected to reach $345 billion in 2023, with estimates of nearly $1 trillion by 2050. This surge in neurological disorders underscores the growth of the cerebrospinal fluid (CSF) devices market.
An increase in the number of brain surgeries contributes to the demand for cerebrospinal fluid (CSF) devices. These devices, crucial in treating traumatic brain injuries (TBI), particularly utilize shunts to drain accumulated cerebrospinal fluid. In the United States, TBI is a leading cause of death, with 1.5 to 2 million adults and children experiencing it annually. Given the prevalence of brain injuries, the CSF devices market is poised for continual growth.
A significant constraint on the cerebrospinal fluid (CSF) devices market is the high such as lihood of shunt failure or malfunction. Shunts are employed to manage Hydrocephalus, a condition involving the accumulation of excess cerebrospinal fluid (CSF) near the brain. Research published on the National Library of Medicine in 2021 revealed a 30% complication rate within 30 days of shunting procedures, with 58% requiring at least one revision. Trust issues arise due to the substantial shunt failure rate, leading patients to seek alternative treatments.
The latest trend in the cerebrospinal fluid devices market involves the implementation of new and improved sensors. This trend holds potential for boosting growth rates and enhancing diagnostic quality. Addressing the complexities of treating Hydrocephalus, high-precision devices with new sensors and telemetry devices are being explored. Northwestern University's Rogers research group has developed an advanced skin sensor that can reduce malfunctions and the need for brain surgeries. The sensor, utilizing body temperature readings, provides information on CSF leakage and offers distinct heat signatures indicating shunt functionality.
Major players in the cerebrospinal fluid (CSF) devices market are introducing innovative products to meet unmet needs, such as the ReFlow Mini Flusher device. Launched by Anuncia Medical Inc. in July 2023, this second-generation device aims to treat hydrocephalus. Its compact design, reduced size, and simplified operation make it a promising innovation in hydrocephalus treatment.
While the US Food and Drug Administration (FDA) classifies CSF devices as class II devices, regulatory compliance involves a stringent protocol. This includes addressing potential health risks, submitting a cover sheet describing the device, providing a summary report, and ensuring biocompatibility and appropriate labeling. Adhering to these regulatory guidelines may extend the product release timeline and increase overall development costs, impacting the market.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market report are Biometrix Healthcare Pvt. Ltd., Delta Surgical Limited, Medtronic PLC, Stryker Corporation, B. Braun, DePuy Synthes, Olympus Corporation, Nitto Denko Corporation, Terumo Corporation, Mindray Medical International Limited, Mettler-Toledo International Inc., IMI Norgren Ltd., Maquet Getinge Group AB, Karl Storz GmbH & Co. KG, Smiths Medical Inc., Elekta AB, Integra LifeSciences Holdings Corporation, Brainlab AG, Penumbra Inc., Leica Biosystems Inc., Danobat S. Coop., Fujifilm Medical Systems USA Inc., Natus Medical Incorporated, G. Surgiwear Ltd., Sophysa USA Inc., Möller Medical GmbH, Wellong Instruments Co. Ltd., Argi Grup, Spiegelberg GmbH & Co. KG, BeckerSmith Medical Inc., Dispomedica GmbH. North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2023. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
The cerebrospinal fluid (CSF) management devices and equipment market research report is one of a series of new reports that provides cerebrospinal fluid (CSF) management devices and equipment market statistics, including cerebrospinal fluid (CSF) management devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid (CSF) management devices and equipment market share, detailed cerebrospinal fluid (CSF) management devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid (CSF) management devices and equipment industry. This cerebrospinal fluid (CSF) management devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Characteristics3. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Trends and Strategies32. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Competitive Benchmarking33. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Competitive Dashboard34. Key Mergers and Acquisitions in the Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
4. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market - Macro Economic Scenario
5. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Size and Growth
6. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Segmentation
7. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Regional and Country Analysis
8. Asia-Pacific Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
9. China Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
10. India Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
11. Japan Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
12. Australia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
13. Indonesia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
14. South Korea Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
15. Western Europe Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
16. UK Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
17. Germany Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
18. France Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
19. Italy Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
20. Spain Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
21. Eastern Europe Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
22. Russia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
23. North America Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
24. USA Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
25. Canada Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
26. South America Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
27. Brazil Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
28. Middle East Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
29. Africa Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
30. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Competitive Landscape and Company Profiles
31. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Other Major and Innovative Companies
35. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Cerebrospinal Fluid Management (CSF) Devices and Equipment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cerebrospinal fluid management (csf) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cerebrospinal fluid management (csf) devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Type: CSF Shunts; CSF Drainage Systems
2) By Age group: Pediatric; Adult; Geriatric
3) By End-user: Hospitals; Ambulatory surgical centers
Subsegment: Ventricular Drainage System; Lumbar Drainage System
Key Companies Mentioned: BioMatrix Healthcare Pvt. Ltd.; Delta Surgical Limited; Medtronic plc; Stryker Corporation; B. Braun
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- BioMatrix Healthcare Pvt. Ltd.
- Delta Surgical Limited
- Medtronic plc
- Stryker Corporation
- B. Braun
- DePuy Synthes
- Olympus Corporation
- Nitto Denko Corporation
- Terumo Corporation
- Mindray Medical International Limited
- Mettler-Toledo International Inc.
- IMI Norgren Ltd.
- Maquet Getinge Group AB
- Karl Storz GmbH & Co. KG
- Smiths Medical Inc.
- Elekta AB
- Integra LifeSciences Holdings Corporation
- Brainlab AG
- Penumbra Inc.
- Leica Biosystems Inc.
- Danobat S. Coop.
- Fujifilm Medical Systems USA Inc.
- Natus Medical Incorporated
- G. Surgiwear Ltd.
- Sophysa USA Inc.
- Möller Medical GmbH
- Wellong Instruments Co. Ltd.
- Argi Grup
- Spiegelberg GmbH & Co. KG
- BeckerSmith Medical Inc.
- Dispomedica GmbH
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 1.16 Billion |
| Forecasted Market Value ( USD | $ 1.22 Billion |
| Compound Annual Growth Rate | 1.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
